How the Johnson & Johnson Medical Devices Companies Are Responding to the Changing Healthcare Landscape

Posted by Brian Chapman on February 27, 2018

This post is the second in a series on the evolution of the medtech commercial model.

The healthcare industry is in the midst of an evolution from volume to value, but it will be a long time before we can say that the old model is behind us. As I wrote in my previous post, this evolution isn’t an overnight transformation but rather a slow burn. This is forcing medtech companies to have “a foot in both worlds:” They must continue partnering with clinical stakeholders while addressing the emerging needs of commercial stakeholders, but at a pace that's in sync with their own evolution. Sometimes that pace is extremely rapid and sometimes feeling a bit more glacial.  


>
Read More

Don’t Call It a Transformation: Four Takeaways From The Medtech Conference

Posted by Brian Chapman on February 20, 2018

This post is the first in a series on the evolution of the medtech commercial model.


I facilitated a panel last fall at The MedTech Conference (formerly the AdvaMed conference) and have continued to think about it. Subsequent conversations with leaders have made me want write down a few thoughts from the day. The panel was called “Driving Growth Through New Commercial Strategies” with medtech experts including Tim Schmid, chief strategic customer officer at Johnson & Johnson Medical Device Companies; Joe Gasque, CMO for the U.S. and Canada at GE Healthcare; and Vince Wong, vice president of strategy and communications at Roche Diagnostics. This group packed the room, and in my humble opinion, the audience seemed pretty engaged.


>
Read More

Value-Based Purchasing: Are You Ready?

Posted by Will Randall on March 23, 2017


Several forces are driving significant changes in the healthcare market, prompting a shift towards value-based healthcare: The reimbursement landscape is changing.


>
Read More